Screener
Eton Pharmaceuticals, Inc. ETON Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | For the three months ended / March 31, 2026 | For the three months ended / March 31, 2025 |
|---|---|---|
| Cost of sales: | ||
| Licensing revenue | — | 825 |
| Product sales and royalties | 9,531 | 6,596 |
| Total cost of sales | 9,531 | 7,421 |
| Gross profit | 14,735 | 9,861 |
| Operating expenses: | ||
| Research and development | 1,875 | 1,161 |
| General and administrative | 10,446 | 9,170 |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s total cost of revenue?
- Eton Pharmaceuticals, Inc. (ETON) reported total cost of revenue of $9.53M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s total cost of revenue changed year-over-year?
- Eton Pharmaceuticals, Inc.'s total cost of revenue increased by 28.4% year-over-year, from $7.42M to $9.53M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s total cost of revenue?
- Over 4 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s total cost of revenue has grown at a 91.1% compound annual growth rate (CAGR), from $2.79M to $37.21M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Eton Pharmaceuticals, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude